Bromodomain PHD‑finger transcription factor promotes glioma progression and indicates poor prognosis

Pan,Yanling; Yuan,Feng; Li,Yijie; Wang,Guoping; Lin,Zhiren; Chen,Longhua

doi:10.3892/or.2018.6832

Bromodomain PHD‑finger transcription factor promotes glioma progression and indicates poor prognosis

Authors:
- Yanling Pan
- Feng Yuan
- Yijie Li
- Guoping Wang
- Zhiren Lin
- Longhua Chen
View Affiliations

Affiliations: Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China, Department of Radiation Oncology, Haikou People's Hospital, Haikou, Hainan 570208, P.R. China
Published online on: October 30, 2018 https://doi.org/10.3892/or.2018.6832
Pages: 246-256
Copyright: © Pan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Glioma is one of the most deadly central nervous system tumors around the world. Uncontrollable cell proliferation and invasion are key factors of cancer progression as well as glioma. Available evidence suggests that bromodomain PHD‑finger transcription factor (BPTF) plays an important role in stem cell proliferation and differentiation, as well as in progression of some tumors, but there is little data on glioma. Therefore, the present study aimed to explore the functional role and potential clinical value of BPTF in glioma. Public database, real‑time PCR and western blotting were used to detect the expression of BPTF in glioma tissue and cells. The relationship between BPTF with clinicopathological features and the prognosis of glioma patients was analyzed by immunohistochemical staining in 113 cases of paraffin‑embedded primary glioma specimens. Furthermore, cytological experiments were conducted to elucidate the functional role of BPTF in glioma U251 cells, as well as the potential molecular mechanism. The expression of BPTF in glioma tissues was significantly higher than that in normal brain tissues. The association analysis results revealed that high BPTF expression was significantly associated with WHO grade and tumor size. Survival analysis revealed that the BPTF high‑expression group had poorer overall survival (OS) and progression‑free survival (PFS) compared with the low‑expression group. Univariate and multivariate Cox regression analyses revealed that BPTF expression was an independent prognostic factor for the OS and PFS of glioma patients. Cytological experiments revealed that BPTF overexpression could significantly promote the proliferation, migration and invasion of human glioma U251 cells. A study of the underlying mechanism indicated that BPTF promoted glioma progression via MYC signaling. Our results preliminarily indicated that BPTF promoted glioma progression via MYC signaling and may be a potential prognostic biomarker and therapeutic target for glioma patients.

View Figures

View References

1	Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LA, Eheman C, Jemal A, Anderson RN, Ajani UA and Edwards BK: Annual report to the nation on the status of cancer, 1975–2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst. 103:714–736. 2011. View Article : Google Scholar : PubMed/NCBI
2	Popova SN, Bergqvist M, Dimberg A, Edqvist PH, Ekman S, Hesselager G, Ponten F, Smits A, Sooman L and Alafuzoff I: Subtyping of gliomas of various WHO grades by the application of immunohistochemistry. Histopathology. 64:365–379. 2014. View Article : Google Scholar : PubMed/NCBI
3	Ho VK, Reijneveld JC, Enting RH, Bienfait HP, Robe P, Baumert BG and Visser O: Dutch Society for Neuro-Oncology (LWNO): Changing incidence and improved survival of gliomas. Eur J Cancer. 50:2309–2318. 2014. View Article : Google Scholar : PubMed/NCBI
4	Hanahan D and Robert W: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
5	Stine ZE, Walton ZE, Altman BJ, Hsieh AL and Dang CV: MYC: metabolism, and cancer. Cancer Discov. 5:1024–1039. 2015. View Article : Google Scholar : PubMed/NCBI
6	Principe DR, Doll JA, Bauer J, Jung B, Munshi HG, Bartholin L, Pasche B, Lee C and Grippo PJ: TG F-β Duality of function between tumor prevention and carcinogenesis. J Natil Cancer Inst. 106:djt3692014. View Article : Google Scholar
7	Wysocka J, Swigut T, Xiao H, Milne TA, Kwon SY, Landry J, Kauer M, Tackett AJ, Chait BT, Badenhorst P, et al: A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature. 442:86–90. 2006. View Article : Google Scholar : PubMed/NCBI
8	Jones MH, Hamana N and Shimane M: Identification and characterization of BPTF, a novel bromodomain transcription factor. Genomics. 63:35–39. 2000. View Article : Google Scholar : PubMed/NCBI
9	Goller T, Vauti F, Ramasamy S and Arnold HH: Transcriptional regulator BPTF/FAC1 is essential for trophoblast differentiation during early mouse development. Mol Cell Biol. 28:6819–6827. 2008. View Article : Google Scholar : PubMed/NCBI
10	Ma Y, Liu X, Liu Z, Wei S, Shang H, Xue Y, Cao Y, Meng A and Wang Q: The chromatin remodeling protein Bptf promotes posterior neuroectodermal fate by enhancing Smad2-activated wnt8a expression. J Neurosci. 35:8493–8506. 2015. View Article : Google Scholar : PubMed/NCBI
11	Richart L, Real FX and Sanchez-Arevalo Lobo VJ: c-MYC partners with BPTF in human cancer. Mol Cell Oncol. 3:e11523462016. View Article : Google Scholar : PubMed/NCBI
12	Xiao S, Liu L, Lu X, Long J, Zhou X and Fang M: The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin. J Cancer Res Clin Oncol. 141:1465–1474. 2015. View Article : Google Scholar : PubMed/NCBI
13	Dai M, Lu JJ, Guo W, Yu W, Wang Q, Tang R, Tang Z, Xiao Y, Li Z, Sun W, et al: BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas. Oncotarget. 6:33878–33892. 2015. View Article : Google Scholar : PubMed/NCBI
14	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
15	Mayes K, Elsayed Z, Alhazmi A, Waters M, Alkhatib SG, Roberts M, Song C, Peterson K, Chan V, Ailaney N, et al: BPTF inhibits NK cell activity and the abundance of natural cytotoxicity receptor co-ligands. Oncotarget. 8:64344–64357. 2017. View Article : Google Scholar : PubMed/NCBI
16	Boruah D, Deb P, Srinivas V and Mani NS: Morphometric study of nuclei and microvessels in gliomas and its correlation with grades. Microvasc Res. 93:52–61. 2014. View Article : Google Scholar : PubMed/NCBI
17	Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P and Ellison DW: The 2016 world health organization classification of tumors of the central nervous system: A summary. Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
18	Minniti G, Muni R, Lanzetta G, Marchetti P and Enrici RM: Chemotherapy for glioblastoma: Current treatment and future perspectives for cytotoxic and targeted agents. Anticancer Res. 29:5171–5184. 2009.PubMed/NCBI
19	Xiao S, Liu L, Fang M, Zhou X, Peng X, Long J and Lu X: BPTF associated with EMT indicates negative prognosis in patients with hepatocellular carcinoma. Dig Dis Sci. 60:910–918. 2015. View Article : Google Scholar : PubMed/NCBI
20	Dar AA, Majid S, Bezrookove V, Phan B, Ursu S, Nosrati M, De Semir D, Sagebiel RW, Miller JR III, Debs R, et al: BPTF transduces MITF-driven prosurvival signals in melanoma cells. Proc Natl Acad Sci USA. 113:6254–6258. 2016. View Article : Google Scholar : PubMed/NCBI
21	Landry J, Sharov AA, Piao Y, Sharova LV, Xiao H, Southon E, Matta J, Tessarollo L, Zhang YE, Ko MS, et al: Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells. PLoS Genet. 4:e10002412008. View Article : Google Scholar : PubMed/NCBI
22	Xu B, Cai L, Butler JM, Chen D, Lu X, Allison DF, Lu R, Rafii S, Parker JS, Zheng D and Wang GG: The chromatin remodeler BPTF activates a stemness gene-expression program essential for the maintenance of adult hematopoietic stem cells. Stem Cell Reports. 10:pp. 675–683. 2018, View Article : Google Scholar : PubMed/NCBI
23	Frey WD, Chaudhry A, Slepicka PF, Ouellette AM, Kirberger SE, Pomerantz WCK, Hannon GJ and Dos Santos CO: BPTF maintains chromatin accessibility and the self-renewal capacity of mammary gland stem cells. Stem Cell Reports. 9:pp. 23–31. 2017, View Article : Google Scholar : PubMed/NCBI
24	Buganim Y, Goldstein I, Lipson D, Milyavsky M, Polak-Charcon S, Mardoukh C, Solomon H, Kalo E, Madar S, Brosh R, et al: A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype. PLoS One. 5:e96572010. View Article : Google Scholar : PubMed/NCBI
25	Dar AA, Nosrati M, Bezrookove V, de Semir D, Majid S, Thummala S, Sun V, Tong S, Leong SP, Minor D, et al: The role of BPTF in melanoma progression and in response to BRAF-targeted therapy. J Natl Cancer Inst. 107:djv0342015. View Article : Google Scholar : PubMed/NCBI
26	Richart L, Carrillo-de Santa Pau E, Río-Machín A, de Andrés MP, Cigudosa JC, Lobo VJ and Real FX: BPTF is required for c-MYC transcriptional activity and in vivo tumorigenesis. Nat Commun. 7:101532016. View Article : Google Scholar : PubMed/NCBI
27	Li Y, Li J, Luo M, Zhou C, Shi X, Yang W, Lu Z, Chen Z, Sun N and He J: Novel long noncoding RNA NMR promotes tumor progression via NSUN2 and BPTF in esophageal squamous cell carcinoma. Cancer Lett. 430:57–66. 2018. View Article : Google Scholar : PubMed/NCBI
28	Jordan-Sciutto KL, Dragich JM, Caltagarone J, Hall DJ and Bowser R: Fetal Alz-50 clone 1 (FAC1) protein interacts with the Myc-associated zinc finger protein (ZF87/MAZ) and alters its transcriptional activity. Biochemistry. 39:3206–3215. 2000. View Article : Google Scholar : PubMed/NCBI